Abstract:Objective: To investigate the clinicopathological, immunohistochemical and molecular characteristics of cutaneous ALK-rearranged Spitz melanocytoma. Methods: Two cases of cutaneous ALK-rearranged Spitz melanocytoma from outside hospital consultations in Department of Pathology, Affiliated Cancer Hospital of Fudan University in August 2020 and in Shanghai Ackermann Medical Laboratory in June 2022 were collected. The clinicopathological features, immunophenotypes and molecular profiles of two patients with cutaneous Spitzoid melanocytic tumor harboring ALK-rearrangement were analyzed. The literatures were reviewed. Results: The study included an 8-year-old boy and an 11-year-old girl, who presented with a polypoid lesion in the skin of right thigh and left auricle measuring 1.0 cm and 1.2 cm, respectively. Histologically, they were composed of medium to large-sized epithelioid to plump spindle cells, arranged in nested, plexiform or fascicular patterns in the superficial dermis. The neoplastic cells had abundant eosinophilic cytoplasm with round to ovoid vesicular nuclei containing prominent eosinophilic nucleoli. One case showed mild to moderate nuclear pleomorphism and mitotic activity (average, 2/mm2). Immunohistochemically, the epithelioid and plump spindle cells showed diffuse and strong staining of S-100 protein, SOX10, and ALK (D5F3 and 1A4), but did not express HMB45, PNL2 and MiTF. ALK-rearrangement was detected by fuorescence in situ hybridization in both cases. Subsequent next generation sequence (NGS) analysis identified KANK1::ALK and TPM3:ALK fusions. At 34 and 14 months after surgical resection, both patients remained well with no signs of recurrence or metastasis. Conclusions: ALK-rearranged Spitz melanocytoma represents a morphologically and genetically distinct subset of Spitz melanocytoma, characterized clinically by predilection in children and adolescents, with Spitzoid morphology in plexiform pattern, positive immunohistochemical stains, and rearrangement of ALK. As some cases show atypical features and high mitotic activity, a distinction from Spitz melanoma is warranted.

Novel <i>MED15::ATF1</i> fusion in a pediatric melanoma with spitzoid features and aggressive presentation

Novel MED15::ATF1 fusion in a pediatric melanoma with spitzoid features and aggressive presentation

MED15::ATF1-rearranged tumor: a novel cutaneous tumor with melanocytic differentiation

Novel ATXN1/ATXN1L::NUTM2A Fusions Identified in Aggressive Infant Sarcomas with Gene Expression and Methylation Patterns Similar to CIC-rearranged Sarcoma

29. when Amplification Meets Gene Fusion: Molecular Characterization of PPP1CB-ALK Fusion and Amplification in Pediatric HGG

Identification of a novel KIF13A-RET fusion in lung adenocarcinoma by next-generation sequencing

A Novel TEK::GAB2 Gene Fusion in Pediatric Angiosarcoma of Pelvic soft Tissue: A Case Report and Literature Review

Spitz melanoma with MAP3K8::ABLIM1 rearrangement: a case report with review of the literature

Novel fusion sarcomas including targetable NTRK and ALK

Pediatric Mesenchymal Tumor With MN1::TAF3 Fusion

The Clinical, Morphologic, and Molecular Spectrum of BRAF Fusion Spitz Tumors

Identification of a novel SH3PXD2B::FER fusion in a case of plexiform myofibroblastic tumor and review of the literature

A Novel Neoplastic Fusion Transcript, RAD51AP1-DYRK4 , Confers Sensitivity to the MEK Inhibitor Trametinib in Aggressive Breast Cancers

Fusion‐driven cutaneous and superficial mesenchymal and adnexal tumors—A clinicopathologic and molecular study of 15 cases, including a novel case of ACTB::ZMIZ2‐rearranged adnexal carcinoma

A Novel Neoplastic Fusion Transcript, <i>RAD51AP1</i>-<i>DYRK4</i>, Confers Sensitivity to the MEK Inhibitor Trametinib in Aggressive Breast Cancers

EZH2-driven immune evasion defines high-risk pediatric AML with t(16;21) FUS::ERG gene fusion.

[ALK rearranged Spitz melanocytoma: a clinicopathological and molecular genetic analysis of two cases]

Clinicopathological Features of Rhabdomyosarcoma with Novel FET::TFCP2 and TIMP3::ALK Fusion: Report of Two Cases and Literature Review

A Pediatric Primary Cardiac Spindle Cell Neoplasm With a Rare PDGFRA::USP8 Gene Fusion: A Case Report

Melanoma in infants, caused by a gene fusion involving the anaplastic lymphoma kinase (ALK)

Spindle cell neoplasms with novel LTK fusion – Expanding the spectrum of kinase fusion‐positive soft tissue tumors